↓ Skip to main content

Novel HDAC inhibitor MAKV-8 and imatinib synergistically kill chronic myeloid leukemia cells via inhibition of BCR-ABL/MYC-signaling: effect on imatinib resistance and stem cells

Overview of attention for article published in Clinical Epigenetics, May 2020
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
3 X users

Readers on

mendeley
32 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Novel HDAC inhibitor MAKV-8 and imatinib synergistically kill chronic myeloid leukemia cells via inhibition of BCR-ABL/MYC-signaling: effect on imatinib resistance and stem cells
Published in
Clinical Epigenetics, May 2020
DOI 10.1186/s13148-020-00839-z
Pubmed ID
Authors

Manon Lernoux, Michael Schnekenburger, Hélène Losson, Koen Vermeulen, Hyunggu Hahn, Déborah Gérard, Jin-Young Lee, Aloran Mazumder, Muneer Ahamed, Christo Christov, Dong-Wook Kim, Mario Dicato, Guy Bormans, Byung Woo Han, Marc Diederich

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 32 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 32 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 4 13%
Professor > Associate Professor 3 9%
Student > Master 3 9%
Student > Postgraduate 2 6%
Student > Doctoral Student 2 6%
Other 4 13%
Unknown 14 44%
Readers by discipline Count As %
Medicine and Dentistry 5 16%
Pharmacology, Toxicology and Pharmaceutical Science 2 6%
Biochemistry, Genetics and Molecular Biology 2 6%
Chemistry 2 6%
Immunology and Microbiology 1 3%
Other 3 9%
Unknown 17 53%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 May 2020.
All research outputs
#15,080,092
of 23,208,901 outputs
Outputs from Clinical Epigenetics
#800
of 1,278 outputs
Outputs of similar age
#231,501
of 389,846 outputs
Outputs of similar age from Clinical Epigenetics
#21
of 35 outputs
Altmetric has tracked 23,208,901 research outputs across all sources so far. This one is in the 32nd percentile – i.e., 32% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,278 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.1. This one is in the 32nd percentile – i.e., 32% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 389,846 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 37th percentile – i.e., 37% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 35 others from the same source and published within six weeks on either side of this one. This one is in the 31st percentile – i.e., 31% of its contemporaries scored the same or lower than it.